XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Restricted Stock Units
Common Stock
Restricted Stock Awards
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   118,811,000          
Beginning balance at Dec. 31, 2021 $ 1,013,953 $ 2     $ 1,527,468 $ (2,627) $ (510,890)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of vested stock options (in shares)   1,712,000          
Exercise of vested stock options 5,324       5,324    
Vesting/Issuance of restricted stock units/awards (in shares)     1,918,000 112,000      
Shares issued under ESPP (in shares)   292,000          
Shares issued under ESPP 2,962       2,962    
Stock-based compensation 98,912       98,912    
Net loss (144,121)           (144,121)
Other comprehensive income (loss) (10,051)         (10,051)  
Ending balance (in shares) at Sep. 30, 2022   122,845,000          
Ending balance at Sep. 30, 2022 966,979 $ 2     1,634,666 (12,678) (655,011)
Beginning balance (in shares) at Jun. 30, 2022   121,885,000          
Beginning balance at Jun. 30, 2022 993,738 $ 2     1,597,869 (12,542) (591,591)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of vested stock options (in shares)   88,000          
Exercise of vested stock options 555       555    
Vesting/Issuance of restricted stock units/awards (in shares)     835,000 37,000      
Shares issued under ESPP (in shares)   0          
Stock-based compensation 36,242       36,242    
Net loss (63,420)           (63,420)
Other comprehensive income (loss) (136)         (136)  
Ending balance (in shares) at Sep. 30, 2022   122,845,000          
Ending balance at Sep. 30, 2022 $ 966,979 $ 2     1,634,666 (12,678) (655,011)
Beginning balance (in shares) at Dec. 31, 2022 124,300,000 124,336,000          
Beginning balance at Dec. 31, 2022 $ 955,158 $ 2     1,666,106 (9,286) (701,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of vested stock options (in shares) 265,000 265,000          
Exercise of vested stock options $ 2,008       2,008    
Vesting/Issuance of restricted stock units/awards (in shares)     4,191,000        
Issuance of restricted stock units related to bonus (in shares)   1,193,000          
Issuance of restricted stock units related to bonus program 16,599       16,599    
Shares issued under ESPP (in shares)   697,000          
Shares issued under ESPP 4,977       4,977    
Stock-based compensation 92,180       92,180    
Net loss (109,702)           (109,702)
Other comprehensive income (loss) $ 7,352         7,352  
Ending balance (in shares) at Sep. 30, 2023 130,700,000 130,682,000          
Ending balance at Sep. 30, 2023 $ 968,572 $ 2     1,781,870 (1,934) (811,366)
Beginning balance (in shares) at Jun. 30, 2023   129,027,000          
Beginning balance at Jun. 30, 2023 987,754 $ 2     1,747,959 (3,152) (757,055)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of vested stock options (in shares)   144,000          
Exercise of vested stock options 1,137       1,137    
Vesting/Issuance of restricted stock units/awards (in shares)     1,511,000        
Shares issued under ESPP (in shares)   0          
Stock-based compensation 32,774       32,774    
Net loss (54,311)           (54,311)
Other comprehensive income (loss) $ 1,218         1,218  
Ending balance (in shares) at Sep. 30, 2023 130,700,000 130,682,000          
Ending balance at Sep. 30, 2023 $ 968,572 $ 2     $ 1,781,870 $ (1,934) $ (811,366)